InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by San Martin Javier, Directeur Médical. Director active across 3 companies, notably Arrowhead Pharmaceuticals, INC.. Cumulatively, 10 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €1.8m. Activity tracked since 19 November 2021. The latest transaction was disclosed on 3 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to San Martin Javier
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
7,418 股0Common StockSEC:0001794629-26-000004:0
4,667 股0Common StockSEC:0001794629-26-000002:0
46,666 股0Common StockSEC:0001415889-25-019068:0
46,667 股0Common StockSEC:0001415889-25-000544:0
75,000 股0Common StockSEC:0001628280-24-000865:0
14,758 股@ US$28.7314.8% 占其流量Common StockSEC:0001628280-23-039850:0
60,000 股0Common StockSEC:0001209191-23-002119:0
19,300 股@ US$29.9821.4% 占其流量COMMON STOCKSEC:0001209191-22-058469:0
200 股@ US$30.620.2% 占其流量COMMON STOCKSEC:0001209191-22-058469:1
13,704 股@ US$69.0146.6% 占其流量Common StockSEC:0001209191-21-066123:0
10 条申报中的 10 条
About San Martin Javier
San Martin Javier is Chief Medical Officer and has filed 10 disclosures in total. Across the 10 sampled filings, they relate to sales of EUR 1786624 between 2021-11-22 and 2026-03-05, with disclosures filed for Arrowhead Pharmaceuticals, INC., Athira Pharma, Inc. and LeonaBio, Inc.
